Emerging role of nitric oxide in cancer

British Journal of Oral and Maxillofacial Surgery

Volumn 37, Issue 5, 1999, Pages 370-373

  Brennan, P A ^a,c   Downie, I P ^a   Langdon, J D ^b   Zaki, G A ^c  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; N(G) METHYLARGININE; NITRIC OXIDE;

CANCER INHIBITION; HEAD AND NECK CANCER; HUMAN; METASTASIS; NONHUMAN; SEPTIC SHOCK; SHORT SURVEY; SOLID TUMOR; TUMOR PROMOTION;

EID: 0032736076     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjom.1999.0201     Document Type: Short Survey

References (45)

1. Moncada S, Martin JF. Evolution of nitric oxide. Lancet 1993; 341:1511.
2. Lincoln J, Hoyle CHV. Nitric oxide in health and disease. Biomedical Research Topics. Cambridge: Cambridge University Press, 1997.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelial-derived relaxing factor. Nature 1987; 327:524-526.
4. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhari G. Endothelial-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9269.
5. Radomski MW, Martin JF, Moncada S. Synthesis of nitric oxide by the haemocytes of the American horseshoe crab. Phil Trans R Soc Lond Biol Sci 1991; 334:129-133.
6. Ignarro IJ, Lippton H, Edwards JC et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218:739-749.
7. Synder SH, Bredt DS. Biological roles of nitric oxide. Sci Am 1992; 266:28-35.
8. Hope BT, Michael GJ, Knigge KM, Vincent SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 1991; 88:2811-2814.
9. Pipili-Synetos E, Sakkoula E, Haralapoulos G, Andriopoulou P, Peristeris P, Maragoudakis ME. Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 1994; 11:894-902.
10. Lau YT, Ma WC. Nitric oxide inhibits migration of cultured endothelial cells. Biochem Biophys Res Commun 1996; 221:670-674.
11. Shan SQ, Rosner GL, Braun RD, Hahn J, Pearce C, Dewhirst MW Effects of diethylamine/nitric oxide on blood perfusion and oxygenation in the R3230Ac mammary carcinoma. Br J Cancer 1997; 76(4):429-437.
12. Gallo O, Masini E, Morbidelli L et al. Role of nitric oxide in angiogenesis and tumour progression in head and neck cancer. J Natl Cancer Inst 1998; 90:587-596.
13. Hibbs JBJ, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157:87-94.
14. Li LM, Kilbourn RG, Adams J, Fidler IJ. Role of nitric oxide in lysis of tumour cells by cytokine activated endothelial cells. Cancer Res 1991; 53:5507-5511.
15. Xie K, Huang S, Dong Z et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 1995; 181:1333-1343.
16. Nicotera P, Bonfoco E, Brüne B. Mechanisms for nitric oxide-induced cell death: involvement of apoptosis. Adv Neuroimmunol 1995; 5:411-420.
17. Liu R, Oberley TD, Oberley LW. Effects of endothelial nitric oxide synthase gene on the tumour biology of human oral carcinoma SCC-25 cells. Cell Growth Differ 1998; 9:239-246.
18. Pipili-Synetos E, Papageorgious A, Sakkoula E et al. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 1995; 1829-1834.
19. Moochhala S, Chhatwal VJ, Chan ST, Ngoi SS, Chia YW, Rauff A. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996; 17:1171-1174.
20. Jansson OT, Morcos E, Brundin L, Bergerheim US, Adolfsson J, Wilkund NP. Nitric oxide synthase in human renal cell carcinoma. J Urol 1998; 160:556-560.
21. Hajri A, Metzger E, Vallat F et al. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies. Br J Cancer 1998; 78:841-849.
22. Thomsen LL, Lawton FG, Knowles RG, Beesely JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynaecological cancer. Cancer Res 1994; 54:1352-1354.
23. Thomsen LL, Miles DW, Happerfield LC, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995; 72:41-44.
24. Rosbe KW, Prazma J, Petrusz P et al. Immunohistochemical characterisation of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 1995; 113:541-549.
25. Orucevic A, Lala PK. Effects of N(g)-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumour responses in healthy and tumor bearing mice. Cancer Immunol Immunother 1996; 42:38-46.
26. Chinje EC, Stratford IJ. Role of nitric oxide in growth of solid tumours: a balancing act. Essays Biochem 1997; 32:61-72.
27. Sessa WC. The nitric oxide synthase family of proteins. J Vasc Res 1994; 31:131-143.
28. Bentz BG, Haines K, Hanson DG, Radosevich JA. Endothelial constitutive nitric oxide synthase (ecNOS) localisation in normal and neoplastic salivary tissue. Head and Neck 1998; 20:304-309.
29. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 1993; 269:12231-12234.
30. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-551.
31. Archer S. Measurement of nitric oxide in biological models. Fed Am Soc Exp Biol J 1993; 7:349-360.
32. Petrusz P, Merchenthaler I, Weinberg RJ, Grossman G, Ordronneau P. Characterisation of an antiserum to citrulline for use in immunocytochemistry. J Histochem Cytochem 1993; 41:1126.
33. Springall DR, Riveros-Moreno V, Buttery L et al. Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms. Histochemistry 1992; 98:259-266.
34. Hevel JM, Marletta MA. Nitric oxide synthase assays. Method Enzymol 1994; 233:250-258.
35. Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 1998; 82:1897-903.
36. Arias-Diaz J, Vara E, Torres-Molero J et al. Nitrite/nitrate and cytokine levels in bronchoalveolar lavage fluid of lung cancer patients. Cancer 1994; 74:1546-1551.
37. Stamler JS. Redox signalling: nitrolysation and related target interactions of nitric oxide. Cell 1994; 78:931-936.
38. Rossaint R, Falke KJ, Lopez F, Slarra K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405.
39. Hirano S. In vitro and in vivo cytotoxic effects of nitric oxide on metastatic cells. Cancer Lett 1997; 115:57-62.
40. Jenkins DC, Charles IG, Thomsen LL et al. Roles of nitric oxide in tumour growth. Proc Natl Acad Sci USA 1995; 92:4392-4396.
41. Lejeune P, Lagade CP, Onier N, Pinard D, Ohshima H, Jeannin JF. Nitric oxide involvement in tumor-induced immunosupression. J Immunol 1994; 152:5077-5083.
42. Nogushi Y, Fujii S, Beppu T, Ogawa M, Maeda H. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 1996; 77:1598-1604.
43. Mills CD. Molecular basis of 'suppressor' macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J Immunol 1991; 146:2719-2723.
44. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558.
45. Andrade SP, Hart IR, Piper PJ. Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br J Pharmacol 1992; 107:1092-1095.